Calcification of abdominal aorta in patients recently starting hemodialysis : a single-center experience from Egypt

Abstract EN

Vascular calcification (VC) is a well-known complication in patients with chronic kidney disease (CKD).

Keeping in mind, the end goal to assess the genuine effect of mineral bone disease in the pathogenesis of blood vessel calcification during the pre-dialysis course of CKD, we assessed the prevalence and extent of abdominal aortic calcification (AAC) in nondiabetic CKD patients recently starting hemodialysis (HD).

Eighty-one patients with end-stage renal disease beginning HD over a one-month period were selected.

They underwent a detailed clinical examination and laboratory evaluation, including serum calcium, phosphorus, parathyroid hormone, fibroblast growth factor (FGF-23), and alkaline phosphatase were measured, and spiral computed tomography was performed to evaluate AAC score.

AAC was present in 64 patients (79%).

There was a significant correlation between the AAC score and age (r = 0.609, P <0.001) and FGF-23 (r = 0.800, P <0.001).

This study suggests that the prevalence and extent of AAC are critical in incident HD patients.

Serum FGF-23 level is the sole statistically significant correlate of AAC in these patients.